Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orvepitant in Chronic Refractory Cough
NCT02993822Phase 2Completed
- Sponsor
- NeRRe Therapeutics
- Start
- May 2017
- Primary completion
- Jan 2019
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of orvepitant in refractory chronic cough (RCC), sponsored by NeRRe Therapeutics. Started May 2017; status: completed.
02
Drugs
orvepitant
03
Conditions
refractory chronic cough (RCC)
Beyond the preview
Go deeper on NCT02993822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02993822.